首页 | 本学科首页   官方微博 | 高级检索  
检索        

组蛋白去乙酰基酶在前列腺癌中的作用及机制研究
引用本文:黄勇,闫骏,马敏.组蛋白去乙酰基酶在前列腺癌中的作用及机制研究[J].中国医药导报,2013,10(26):13-15.
作者姓名:黄勇  闫骏  马敏
作者单位:内蒙古医科大学附属医院泌尿外科,内蒙古呼和浩特,010050
基金项目:国家自然科学基金自助项目
摘    要:目的 研究组蛋白去乙酰基酶在前列腺癌中的作用及机制.方法 采用LNCaP细胞系建立前列腺癌异种移植体动物模型,分为对照组和HDAC抑制剂组,对照组动物常规饲养,HDAC抑制剂组采用0.4%HDAC抑制剂丙戊酸(VPA)饮用水连续饮用35 d.免疫组化法检测乙酰化组蛋白H3、p21WAF1/CIP1、p27KIP1、细胞周期蛋白D1、雄激素受体(AR)表达.结果 与对照组相比,HDAC抑制剂组乙酰化组蛋白H3阳性染色MOD值显著升高(0.63±0.12)比(0.75±0.11),P<0.05],p21 WAF1/CIP1(0.27 ±0.06)比(0.79±0.10),P<0.05]和p27KIP1 (0.31 ±0.08)比(1.09±0.18),P<0.05]阳性染色MOD值显著增加,细胞周期素D1的阳性染色MOD值显著减少(0.69±0.09)比(0.58±0.08),P< 0.05],AR阳性染色MOD值显著降低(0.62±0.10)比(0.53±0.07),P<0.05].结论 HDAC参与前列腺癌细胞的细胞周期调控并与AR过表达有关,HDACI可通过诱导癌细胞周期阻滞及下调AR表达水平等机制抑制前列腺癌肿瘤移植体生长.

关 键 词:组蛋白去乙酰基酶  前列腺癌  丙戊酸  细胞周期  雄激素受体

The roles of histone deacetylase in prostate cancer and its mechanisms
HUANG Yong , YAN Jun , MA Min.The roles of histone deacetylase in prostate cancer and its mechanisms[J].China Medical Herald,2013,10(26):13-15.
Authors:HUANG Yong  YAN Jun  MA Min
Institution:Department of Urinary Surgery, the Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia Autonomous Region, Huhhot 010050, China
Abstract:Objective To explore the roles of histone deacetylase in prostate cancer and its underlying mechanisms. Methods Prostate cancer xenotransplantation animal model was established with LNCaP cell line, animals were ran- domized into control group and HDACI treatment group. Experimental animals in HDACI treatment group were treated with 0.4% VPA in drinking water for 35 days, while animals in control group were fed routinely. The acetylation status of histone H3 and expression of p21WAFI/CIP1, p27 KIP1, Cyclin D1 and AR in excised xenografts were assayed by im- munohistochemistry. Results Compared with the control group, the MOD of positive staining of acetylated histone H3 (0.63±0.12) vs (0.75±0.11), P 〈 0.05] and the MOD of positive staining of p21 WAFI/CIP1 (0.27±0.06) VS (0.79±0.10), P 〈 0.05] and p27 KIP1 (0.31±0.08) VS (1.09±0.18), P 〈 0.05] in HDACI treatment group significantly increased, while the MOD of positive staining of cyclin D1 (0.69±0.09) vs (0.58±0.08), P 〈 0.05] and AR (0.62±0.10) vs (0.53±0.01), P 〈 0.05] significantly reduced. Conclusion HDAC is involved in regulation of cell cycle and is associated with over-expression of AR, HDACI inhibits tumor growth by multiple mechanisms including cell cycle arrest, and inhibition of AR.
Keywords:Histone deacetylase  Prostate cancer  VPA  Cell cycle  AR
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号